A photo of Cuixia Tian.

Cuixia Tian, MD


  • Director, MDA Clinic and PPMD Certified DMD Clinic, Division of Neurology
  • Neuromuscular Disease Specialist, Division of Neurology
  • Associate Professor, UC Department of Pediatrics
My team and I are focused on families' concerns and work together to provide the best care possible to our patients.
Cuixia Tian, MD

About

Biography

I'm a board-certified child neurologist who specializes in neuromuscular diseases. I am co-director of the multidisciplinary comprehensive neuromuscular care program and serve as the program's neurology lead. I'm also the clinical director of the Parent Project Muscular Dystrophy (PPMD) Certified Duchenne Muscular Dystrophy (DMD) Clinic and clinical director of the Muscular Dystrophy Association (MDA) Care Center.

My mom was a devoted elementary teacher, loved by many of her students. Her love for children inspired me, and I became a pediatrician. I am honored to be recognized by Cincinnati Magazine’s Top Doctors in Pediatric Neurology (2023).

I'm passionate about caring for children and young adults with chronic neuromuscular disease. I love meeting families and listening to parents advocating for their children. My team and I are focused on families' concerns and work together to provide the best care possible to our patients.

As a clinical researcher, I actively lead and collaborate on multiple clinical trials and research studies in pediatric neuromuscular diseases to develop advanced therapies and improve clinical care for our patients.

When I'm not at work, I love music and the arts. I also enjoy gardening and playing tennis.

MD: Medical Center of Fudan University, Shanghai, China, 1993.

Residency: Cincinnati Children’s Hospital Medical Center.

Myology Institute Clinical Myology Training; Paris, France, 2014.

Wellstone Myology Training; Ohio State University, Columbus, OH, 2013.

World Muscle Society Satellite Training; Asilomar, California, 2013.

Additional Languages

Chinese

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. Jennings, K; Tian, C; Brown, RL; Horn, PS; Schoser, B; Kushlaf, H; Timchenko, NA; Timchenko, L. International Journal of Molecular Sciences. 2025; 26:10760.

Delphi study to elicit expert consensus around decision-making in the treatment of Friedreich ataxia. Kuo, SH; Tian, C; McKay, J; England, SM; Simon, M; Graf, M; Brewer, IP; Land, N; Chou, JW; Lawson, R. Frontiers in Neurology. 2025; 16:1669059.

Epicardial Adipose Tissue in Duchenne Muscular Dystrophy Cardiomyopathy. Greiner, E; Miles, KG; Gao, Z; Lang, SM; Ryan, TD; Ollberding, NJ; Mantell, BS; Rutter, MM; Tian, C; Villa, CR. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2025; 14:e042300.

Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T. Foley, AR; Bolduc, V; Guirguis, F; Donkervoort, S; Hu, Y; Orbach, R; Mccarty, RM; Sarathy, A; Norato, G; Cummings, BB; Wagener, R; Bertini, E; Muntoni, F; Bönnemann, CG. Brain: a journal of neurology. 2025; 148:3215-3227.

292PDuchenne muscular dystrophy newborn screening via elevated serum creatine phosphokinase resulting in alternate diagnoses: a single center experience. Zygmunt, A; Vilaisaktipakorn, P; Nagaraj, C; Reebals, L; Tian, C. Neuromuscular Disorders. 2025; 53:105926.

672PFrom case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians. Tian, C; Nasomyont, N; Ryan, T; Villa, C; Reebals, L; Zygmunt, A; Rutter, M. Neuromuscular Disorders. 2025; 53:105648.

637PAssessment of transition readiness for pediatric patients with Duchenne muscular dystrophy. Vilaisaktipakorn, P; Sawnani, A; Gurbani, N; Pascoe, J; Stewart, C; Horn, P; Bange, J; Zygmunt, A; Tian, C. Neuromuscular Disorders. 2025; 53:106171.

186PPerformance of upper limb in steroid-treated Duchenne muscular dystrophy: genotype-phenotype correlations. Wade, C; Zygmunt, A; Horn, P; Bonarrigo, K; Reebals, L; Rybalsky, I; Tian, C. Neuromuscular Disorders. 2025; 53:105539.

RNA Sequencing Confirms the Pathogenicity of a Novel FHL1 Deletion in a Kinship With Emery-Dreifuss Muscular Dystrophy. Nagaraj, CB; Tian, C; Kushlaf, H. Journal of Clinical Neuromuscular Disease. 2025; 26:148-151.

Clinical characterization of Collagen XII-related disease caused by biallelic COL12A1 variants. McCarty, RM; Saade, D; Munot, P; Laverty, CG; Pinz, H; Zou, Y; McAnally, M; Yun, P; Tian, C; Hu, Y; Muntoni, F; Straub, V; Donkervoort, S; Bönnemann, CG. Annals of Clinical and Translational Neurology. 2025; 12:602-614.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...